Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nippon Chemical Industrial Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Upward by 24%, Dividend Revised Upward by 22 yen
4092 Nippon Chemical Industrial Co.,Ltd. 【J-GAAP】
Earnings ReportNippon Chemical Industrial Co.,Ltd. <4092> [TSE-P] announced its financial results after the market closed on November 12th (16:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) surged by 2.6 times that of the same period last year, reaching 2.39 billion yen.
In addition, the full-year consolidated ordinary profit has been revised upward by 24.1%, from the previous forecast of 2.9 billion yen to 3.6 billion yen (compared to 2.38 billion yen in the previous period), increasing the growth rate from 21.7% to 51.1%.
Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to decrease by 18.1% from the same period last year to 1.2 billion yen.
In light of the strong performance, the company has significantly increased its planned annual dividend for the current fiscal year from the original plan of 70 yen to 92 yen (compared to 70 yen in the previous period).
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased by 42.0% from the same period last year, reaching 652 million yen. The operating profit margin improved from 4.7% in the same period last year to 6.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2022 | 19,653 | 992 | 1,123 | 735 | 83.5 | 79.5 | Nov 10, 2022 | J-GAAP |
Apr - Sep, 2023 | 18,672 | 803 | 909 | 611 | 69.3 | 38.1 | Nov 10, 2023 | J-GAAP |
Apr - Sep, 2024 | 20,678 | 2,401 | 2,393 | 1,633 | 185.1 | 66.5 | Nov 12, 2024 | J-GAAP |
YoY | +10.7% | +199.0% | +163.3% | +167.3% | +167.0% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 Guidance | ー | ー | ー | ー | - | 35 | May 14, 2024 | J-GAAP |
Apr - Sep, 2024 Results | 20,678 | 2,401 | 2,393 | 1,633 | 185.1 | 46 | Nov 12, 2024 | J-GAAP |
Revision Rate | - | - | - | - | - |
Guidance Update
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 40,000 | 2,900 | 2,900 | 2,000 | 226.7 | 70 | May 14, 2024 | J-GAAP |
Mar, 2025 New | 40,000 | 3,600 | 3,600 | 2,600 | 294.8 | 92 | Nov 12, 2024 | J-GAAP |
Revision Rate | 0.0% | +24.1% | +24.1% | +30.0% | +30.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 19,866 | 1,461 | 1,474 | 979 | 111.1 | 35 | May 14, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 19,322 | 1,199 | 1,207 | 967 | 109.6 | 46 | Nov 12, 2024 | J-GAAP |
YoY | -2.7% | -17.9% | -18.1% | -1.2% | -1.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 38,075 | 1,292 | 1,412 | 855 | 97.1 | 70 | May 11, 2023 | J-GAAP |
Mar, 2024 | 38,538 | 2,264 | 2,383 | 1,590 | 180.4 | 70 | May 14, 2024 | J-GAAP |
Mar, 2025 Guidance | 40,000 | 3,600 | 3,600 | 2,600 | 294.8 | 92 | Nov 12, 2024 | J-GAAP |
YoY | +3.8% | +59.0% | +51.1% | +63.5% | +63.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Sep, 2023 | 9,742 | 454 | 459 | 324 | 36.8 | 4.7 | Nov 10, 2023 | J-GAAP |
Oct - Dec, 2023 | 9,989 | 844 | 851 | 632 | 71.7 | 8.4 | Feb 8, 2024 | J-GAAP |
Jan - Mar, 2024 | 9,877 | 617 | 623 | 347 | 39.4 | 6.2 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 10,379 | 1,688 | 1,741 | 1,252 | 141.9 | 16.3 | Aug 6, 2024 | J-GAAP |
Jul - Sep, 2024 | 10,299 | 713 | 652 | 381 | 43.2 | 6.9 | Nov 12, 2024 | J-GAAP |
YoY | +5.7% | +57.0% | +42.0% | +17.6% | +17.5% |
Related Articles
SHIBAURA MACHINE CO., LTD., The Current Fiscal Year Ordinary Profit Revised Upward by 5%
UNBANKED,INC., 84% Increase in Undisclosed Ordinary Profit for First Half
Kidswell Bio Corporation, The Current Fiscal Year's Net Income to Narrow
Virtualex Holdings,Inc., July-September (2Q) Ordinary Profit Increases by 45%
KAN-NANMARU CORPORATION, July-September (1Q) Ordinary Profit Loss Narrows
Fuji Pharma Co.,Ltd., 5% Increase in Ordinary Profit, Record High for The First Time in Eight Years, Dividend to Rise by 3 yen
INTERMESTIC INC., January-September (Third Quarter Cumulative) Ordinary Profit 5.3 billion yen, Exceeds Full-Year Plan
AOYAMA TRADING Co., Ltd., The Current Fiscal Year Ordinary Profit Revised Upward by 4%, Dividend Revised Upward by 66 yen
JFLA Holdings Inc., First Half Ordinary Profit Increases by 6.9 times, Exceeds Full-Year Plan
Landix Inc., First Half Ordinary Profit Increases by 23%, July-September Ordinary Profit Increases by 2.3 times